Cargando…

Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis

Idiopathic pulmonary arterial hypertension (IPAH) is a rare vascular disease with a poor prognosis, and the mechanism of its development remains unclear. Further molecular pathology studies may contribute to a comprehensive understanding of IPAH and provide new insights into diagnostic markers and p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Hua-Xi, Qiu, Bai-Quan, Lai, Song-Qing, Zhou, Xue-Liang, Gong, Cheng-Wu, Wang, Li-Jun, Yuan, Ming-Ming, He, An-Di, Liu, Ji-Chun, Huang, Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556088/ https://www.ncbi.nlm.nih.gov/pubmed/34722766 http://dx.doi.org/10.1155/2021/5669412

Ejemplares similares

Role of ferroptosis-related genes in Stanford type a aortic dissection and identification of key genes: new insights from bioinformatic analysis
por: Zou, Hua-Xi, et al.
Publicado: (2021)

Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses
por: Qiu, Xue, et al.
Publicado: (2021)

Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis
por: Wang, Li-Jun, et al.
Publicado: (2022)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related Biomarkers in Septic Cardiomyopathy via Bioinformatics Analysis
por: Gong, Cheng-Wu, et al.
Publicado: (2022)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
por: Howard, Luke S.G.E., et al.
Publicado: (2013)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning
por: Lu, Wenzhang, et al.
Publicado: (2023)

Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
por: Zeng, Haowei, et al.
Publicado: (2021)

Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension
por: Yan, Lu, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension: Iron Matters
por: Ramakrishnan, Latha, et al.
Publicado: (2018)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Impact of right ventricular dyssynchrony on prognosis of patients with idiopathic pulmonary arterial hypertension
por: Cheng, Xiao-Ling, et al.
Publicado: (2019)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies
por: Yang, Xiaomei, et al.
Publicado: (2022)

Bioinformatic exploration of the immune related molecular mechanism underlying pulmonary arterial hypertension
por: Huang, Ruina, et al.
Publicado: (2021)

Epistatic interactions in idiopathic pulmonary arterial hypertension
por: Vadapalli, Shivani, et al.
Publicado: (2012)

Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension
por: Yuan, Ping, et al.
Publicado: (2017)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study
por: Qian, Yuling, et al.
Publicado: (2023)

Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension
por: Edgar, Alasdair J, et al.
Publicado: (2006)

Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Association of Rare PTGIS Variants With Susceptibility and Pulmonary Vascular Response in Patients With Idiopathic Pulmonary Arterial Hypertension
por: Wang, Xiao-Jian, et al.
Publicado: (2020)

Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―
por: Ishiguro, Midori, et al.
Publicado: (2020)

Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Fang, Wei, et al.
Publicado: (2012)

Dysregulated autophagy-related genes in septic cardiomyopathy: Comprehensive bioinformatics analysis based on the human transcriptomes and experimental validation
por: Zou, Hua-Xi, et al.
Publicado: (2022)

Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension
por: Lin, Wenchao, et al.
Publicado: (2022)

Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
por: van der Have, Oscar, et al.
Publicado: (2023)

Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials
por: Howard, Luke S. G. E., et al.
Publicado: (2021)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines
por: Zhong, Dong-Xiang, et al.
Publicado: (2021)

Idiopathic hypereosinophilic syndrome with pulmonary hypertension
por: Zhang, Liping, et al.
Publicado: (2018)

Increased plasma expression of a disintegrin and metalloproteinase with thrombospondin motifs like 4 in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Li, Yan, et al.
Publicado: (2023)

NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification
por: Fu, Bowen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mb51o78ik7mv4s5ss2v524vr01